<DOC>
	<DOCNO>NCT00804271</DOCNO>
	<brief_summary>To validate new Alzheimer 's Disease scale rating tool subject dementia Alzheimer 's type , treat memantine .</brief_summary>
	<brief_title>Memantine Validation New Alzheimer 's Disease Scale</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Memantine</mesh_term>
	<criteria>Diagnosis probable Alzheimer 's disease consistent NINCDSADRDA criterion DSM IV TR criterion Dementia Alzheimer 's type . Signed informed consent prior initiation study specific procedure . Sight hearing ( hear aid permit ) sufficiently good allow undertake studyrelated procedure psychometric test . Evidence clinically significant active pulmonary , gastrointestinal , renal , hepatic , endocrine cardiovascular system disease . Intake medication contraindicate combination memantine . History severe drug allergy , hypersensitivity , patient know hypersensitivity ingredient memantine lactose . Known suspected history alcoholism drug abuse within past 2 year . Current previous treatment memantine participation investigational study memantine .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>